Biostar Microtech International Corp. (TPE:2399)
Taiwan · Delayed Price · Currency is TWD 45.10
-0.05 (-0.11%)
Aug 19, 2026, 1:30 PM CST
TPE:2399 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,747 | 1,734 | 2,019 | 2,344 | 2,236 | 2,775 | |
Revenue Growth | -3.72% | -14.09% | -13.89% | 4.83% | -19.40% | 31.85% |
Cost of Revenue | 1,564 | 1,622 | 1,853 | 2,209 | 1,968 | 2,255 |
Gross Profit | 182.98 | 111.97 | 165.94 | 135.35 | 268.62 | 520.13 |
Selling, General & Admin | 260.56 | 189.79 | 200.56 | 191.81 | 194.01 | 230.04 |
Research & Development | 114.17 | 75.35 | 71.13 | 73.56 | 71.88 | 98.07 |
Operating Expenses | 374.65 | 264.06 | 272.86 | 265.15 | 267.09 | 303.42 |
Operating Income | -191.67 | -152.09 | -106.93 | -129.81 | 1.53 | 216.71 |
Interest Expense | -0.42 | -0.05 | -0.12 | -0.15 | -0.13 | -0.05 |
Interest & Investment Income | 34.51 | 42.61 | 43.1 | 35.42 | 29.19 | 21.61 |
Currency Exchange Gain (Loss) | -32.48 | -32.48 | 49.64 | 5.88 | 53.91 | -6.12 |
Other Non Operating Income (Expenses) | 809.12 | -23.67 | 11.74 | 17.93 | 22.34 | 20.55 |
EBT Excluding Unusual Items | 619.06 | -165.67 | -2.57 | -70.73 | 106.85 | 252.71 |
Gain (Loss) on Sale of Investments | 192.73 | 192.73 | 30.73 | -46.29 | -90.65 | 154.25 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.12 |
Pretax Income | 811.79 | 27.06 | 28.17 | -117.02 | 16.21 | 406.84 |
Income Tax Expense | 105.19 | 0.9 | 21.55 | -3.66 | 3.36 | 45.17 |
Earnings From Continuing Operations | 706.6 | 26.16 | 6.62 | -113.36 | 12.85 | 361.68 |
Net Income to Company | 706.6 | 26.16 | 6.62 | -113.36 | 12.85 | 361.68 |
Net Income | 706.6 | 26.16 | 6.62 | -113.36 | 12.85 | 361.68 |
Net Income to Common | 706.6 | 26.16 | 6.62 | -113.36 | 12.85 | 361.68 |
Net Income Growth | - | 295.23% | - | - | -96.45% | 153.47% |
Shares Outstanding (Basic) | 179 | 178 | 178 | 178 | 178 | 178 |
Shares Outstanding (Diluted) | 181 | 178 | 178 | 178 | 179 | 180 |
Shares Change | 1.46% | 0.01% | 0.09% | -0.46% | -0.79% | 0.84% |
EPS (Basic) | 3.94 | 0.15 | 0.04 | -0.64 | 0.07 | 2.03 |
EPS (Diluted) | 3.91 | 0.15 | 0.04 | -0.64 | 0.07 | 2.01 |
EPS Growth | - | 295.23% | - | - | -96.52% | 151.25% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -239.07 | -138.8 | 63.26 | 28.28 | -82.86 | 89.22 |
Free Cash Flow Per Share | -1.32 | -0.78 | 0.35 | 0.16 | -0.46 | 0.49 |
Dividend Per Share | - | - | - | - | - | 1.200 |
Dividend Growth | - | - | - | - | - | 200.00% |
Gross Margin | 10.48% | 6.46% | 8.22% | 5.77% | 12.01% | 18.75% |
Operating Margin | -10.97% | -8.77% | -5.30% | -5.54% | 0.07% | 7.81% |
Profit Margin | 40.46% | 1.51% | 0.33% | -4.83% | 0.57% | 13.03% |
Free Cash Flow Margin | -13.69% | -8.00% | 3.13% | 1.21% | -3.71% | 3.21% |
EBITDA | -186.57 | -146.88 | -101.97 | -125.17 | 6.55 | 223.86 |
EBITDA Margin | -10.68% | -8.47% | -5.05% | -5.34% | 0.29% | 8.07% |
D&A For EBITDA | 5.1 | 5.2 | 4.96 | 4.63 | 5.02 | 7.14 |
EBIT | -191.67 | -152.09 | -106.93 | -129.81 | 1.53 | 216.71 |
EBIT Margin | -10.97% | -8.77% | -5.30% | -5.54% | 0.07% | 7.81% |
Effective Tax Rate | 12.96% | 3.31% | 76.50% | - | 20.71% | 11.10% |